Results 101 to 110 of about 30,905 (165)

Salient Observations from Clinical Profile and Long-Term Outcome of a Cohort of Patients with Ectopic Cushing's Syndrome. [PDF]

Indian J Endocrinol Metab
Arjunan D, Jain N, Shah R, Ahuja CK, Mavuduru RS, Bora GS, Pal R, Bhadada SK, Bhansali A, Basher RK, Saikia UN, Walia R.   +11 more
europepmc   +1 more source

Concurrent head and neck paragangliomas and pulmonary carcinoid tumor: A rare clinical entity. [PDF]

Radiol Case Rep
Nisar F, Rhim HJ, Finocchiaro R, Jain V.
europepmc   +1 more source

Serum 5-Hydroxyindoleacetic Acid Measurements for the Diagnosis and Follow-up of Carcinoid Syndrome.

J Clin Endocrinol Metab
Kerolles M, Mulders MCF, Mirzaian M, van den Berg SAA, Feelders RA, de Herder WW, Hofland J.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Malignant Carcinoid Syndrome

Archives of Surgery, 1959
The malignant carcinoid syndrome is manifested by (1) paroxysmal flushing, (2) chronic diarrhea, (3) respiratory distress, and (4) valvular heart disease. These abnormalities result from a marked increase in the amount of circulating serotonin. The abnormal clinical findings in this syndrome result principally from the action of serotonin on the ...
Wilson, Harwell, Storer, Edward H.
openaire   +3 more sources

Malignant carcinoid syndrome: Two case reports

Journal of Surgical Oncology, 1980
AbstractThe malignant carcinoid syndrome (MCS) is a rare complication of malignant carcinoid neoplasms, fewer than 200 cases having been reported since its description by Thorson in 1954. Its signs and symptoms vary with the site of the primary neoplasm, and MCS is now recognized as one member of the large family of endocrine tumors ‐ APUDOMAS ...
J L, Spann, D, Van Wormer, M E, Sandlin
openaire   +2 more sources

Metastatic Carcinoid Tumors and the Malignant Carcinoid Syndrome

Annals of the New York Academy of Sciences, 1994
Patients with metastatic carcinoid tumors and the malignant carcinoid syndrome have benefited immensely from diagnostic and therapeutic advances during the past decade. Magnetic resonance imaging and whole body scintigraphy with radiolabelled analogues of somatostatin have improved our ability to diagnose, detect, stage and follow response to therapy ...
openaire   +2 more sources